Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leflunomide in Rheumatoid Arthritis
NCT00280644Phase 4Completed
- Sponsor
- Sanofi
- Start
- Apr 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of leflunomide in rheumatoid arthritis (RA), sponsored by Sanofi. Started Apr 2004; status: completed.
02
Drugs
leflunomide
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00280644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00280644.